COMMUNIQUÉS West-GlobeNewswire

Silexion Therapeutics Announces 1-for-15 Reverse Share Split
16/07/2025
Trading on split-adjusted basis will begin at market open on July 29, 2025. This adjustment is expected to help Silexion comply with NASDAQ requirements, enhance its market position, and support its strategic growth [...]
SeaStar Medical Grows Customer Base and Expands QUELIMMUNE Surveillance Registry
16/07/2025
Highest Rated Children’s Medical Centers Now Employ QUELIMMUNE for Ultra-Rare Cases of Pediatric AKI HDE Surveillance Registry Data Captures Key Metrics for Future Analysis of QUELIMMUNE Performance DENVER, July 16, [...]
Silo Pharma Announces Completion of Dosing in Safety Study of PTSD Drug SPC-15
16/07/2025
SARASOTA, FL, July 16, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today [...]
Henry Ford Health Initiates Patient Enrollment for BioCardia’s CardiAMP HF II Pivotal Study for Ischemic Heart Failure of Reduced Ejection Fraction
16/07/2025
SUNNYVALE, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, announced today [...]
BioAdaptives Announces National Launch of NeuroRush™ — A Cutting-Edge Adaptogenic Nootropic for Mental Clarity, Focus, and Resilience
16/07/2025
NeuroRush™ delivers a unique blend of adaptogens and nootropic herbs designed to enhance cognitive performance, stress response and long-term brain health, without dependency or burnout. LAS VEGAS, July 16, 2025 (GLOBE [...]
CYCLACEL PHARMACEUTICALS COMMENTS ON RECENT STOCK PRICE VOLATILITY
16/07/2025
Kuala Lumpur, Malaysia, July 16, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines, today [...]
Following Psychedelic Science 2025 Success, MAPS Publishes First of Hundreds of Conference Session Videos
16/07/2025
Enhanced Virtual Trip platform goes live with improved user experience and first selection of PS2025 session videos Conference drew 8,000+ attendees, more than $1 million donated, and 1,100+ recurring donors joined the [...]
Lattimore Physical Therapy & Sports Rehabilitation Network Rolls Out Athelas Air to 35 Locations
16/07/2025
Lattimore selects Athelas Air to transform revenue operations and EHR performance, consolidating its tech stack, improving margins, and enabling real-time access to financial and clinical insights MOUNTAIN VIEW, Calif [...]
Vivid Dx Appoints Diagnostics Veteran John Sperzel as Chief Executive Officer and Board Member
16/07/2025
OXFORD, United Kingdom, July 16, 2025 (GLOBE NEWSWIRE) -- Vivid Dx, a precision diagnostics company transforming pathogen detection and antimicrobial resistance (AMR) testing, today announced the appointment of John [...]
Gain Therapeutics Announces Pricing of $7.0 Million Public Offering
16/07/2025
BETHESDA, Md., July 16, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of [...]
Intuitive demonstrates telesurgery capabilities
16/07/2025
SUNNYVALE, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, has today demonstrated its telesurgery [...]
OKYO Pharma Unveils Strong Phase 2 Clinical Trial Results for Urcosimod to Treat Neuropathic Corneal Pain
16/07/2025
After 12 weeks of treatment, 75% of per-protocol patients receiving 0.05% urcosimod showed greater than 80% reduction in neuropathic corneal pain (NCP), as measured by Visual Analogue Scale (VAS), demonstrating highly [...]
Windtree To Launch BNB Crypto Treasury Strategy With Agreement For $60 Million Investment Led By Build And Build Corp. With Up To $140 Million More In Follow On Subscriptions
16/07/2025
Windtree expected to become a leader and the first NASDAQ-listed company offering direct exposure to the Binance Smart Chain Ecosystem (BNB) WARRINGTON, Pa., July 16, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc [...]
Where to Buy Kratom Online in 2025: Happy Go Leafy Ranked Among the Best Kratom Brands for Quality and Transparency
16/07/2025
Check out this 2025 review of Happy Go Leafy, a top kratom brand offering quality products, a wide variety of strains, and transparency in sourcing and testing. Miami, Florida, July 16, 2025 (GLOBE NEWSWIRE) -- Kratom [...]
Dallas Business Journal Recognizes U.S. Oral Surgery Management for Continued Growth
16/07/2025
IRVING, Texas, July 16, 2025 (GLOBE NEWSWIRE) -- For the second year in a row, the Dallas Business Journal has named Irving’s U.S. Oral Surgery Management ( USOSM ) to this year’s Fast 50 – a list of the 50 fastest [...]
Aesthetic Business Strategist Dr. Kalpana Sundar to Host Transformational Profit Accelerator Bootcamp for Medspa Owners in Albuquerque – August 7–10, 2025
16/07/2025
ALBUQUERQUE, New Mexico, July 16, 2025 (GLOBE NEWSWIRE) -- As the medical aesthetics industry continues to experience exponential growth, many medspa owners and aesthetic providers find themselves overwhelmed — juggling [...]
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2025
16/07/2025
Company Announcement Net sales of DARZALEX ® in the second quarter of 2025 totaled USD 3,539 million Genmab receives royalties on worldwide net sales from Johnson & Johnson (J&J, legal entity Janssen Biotech, [...]
Amphista Therapeutics announces achievement of a research milestone in its collaboration with Merck triggering a milestone payment
16/07/2025
Collaboration focuses on the discovery of novel, non-CRBN/VHL, Targeted Glue™ degraders for oncology and immunology indications Cambridge, UK, 16 July 2025 – Amphista Therapeutics (“the Company” or “Amphista”), a leader [...]
Prime Medicine Announces Additional Funding of Up to $24 Million from the Cystic Fibrosis Foundation to Advance Prime Editing Treatments for Cystic Fibrosis
16/07/2025
-- Expanded funding builds on the initial agreement to accelerate development of Prime Editors for Cystic Fibrosis (CF) -- -- Prime Medicine to receive up to $24 million in additional funding from the Cystic Fibrosis [...]

Pages